Skip to content

Drug interactions

Irinotecan + Ivacaftor

Severity: Minor

Irinotecan and Ivacaftor: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ivacaftor weakly inhibits P-gp and may modestly raise exposure to irinotecan, a P-gp substrate with a narrow therapeutic index. Increased toxicity such as diarrhea and neutropenia is theoretically possible. No clinical data exist for this pair.

What this interaction means in plain words

Irinotecan and Ivacaftor have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Irinotecan belongs to Oncology; Ivacaftor belongs to Miscellaneous.

Evidence level: Low

Why it happens

Ivacaftor and its M1 metabolite weakly inhibit P-gp efflux.

What to do

Monitor for irinotecan toxicity, particularly diarrhea and neutropenia; no routine dose change is needed.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Irinotecan and Ivacaftor, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Irinotecan with Ivacaftor?

MediHelp rates the interaction as minor. Irinotecan and Ivacaftor have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Ivacaftor weakly inhibits P-gp and may modestly raise exposure to irinotecan, a P-gp substrate with a narrow therapeutic index. Increased toxicity such as diarrhea and neutropenia is theoretically possible. No clinical data exist for this pair.

How serious is the interaction between Irinotecan and Ivacaftor?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for irinotecan toxicity, particularly diarrhea and neutropenia; no routine dose change is needed.

What other medicines interact with Irinotecan?

MediHelp also lists interactions of Irinotecan with, for example, Clozapine, Sacituzumab govitecan, Adenovirus types 4 and 7 live. The full list is on the Irinotecan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in